- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT06445530
Optimalizace výživy a povznesení komunity pro zotavení po porodu (NOURISH-GDM)
Optimalizace výživy a povznesení komunity pro zotavení po porodu: Intervence na podporu hojení po gestačním diabetu
The goal of this clinical trial is to better understand how different strategies, timing, and enhancements to medically tailored food delivery will address structural inequities in the food environment, empower communities to sustain behavior change, and ultimately improve postpartum weight control to prevent type 2 diabetes-a potent contributor to disparate mortality among Black women.
The main aims of the study are:
- To conduct a pilot randomized control trial to test the feasibility, acceptability, and effectiveness of a multi-component Medically Tailored Food (MTF) intervention, Moveable Feast ENHANCED (a hybrid MTF intervention with a patient-activated change from prepared meals to fresh food delivery, customized for postpartum people, culturally customized for engagement and adherence, and food provision for dependents) versus MFeast Usual Care (prepared medically tailored foods only)
- To test sustainability and scalability.
Participants will:
- Respond to online surveys (supported by study team members via scheduled phone calls) via REDCap links shared before each study visit at baseline, 3, 6 months post-delivery after the baseline survey.
- Submit anthropometric data (i.e, weight) and information about laboratory results ( e.g. HgbA1C)
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
This study will evaluate the feasibility, acceptability, and preliminary effectiveness of a postpartum dietary intervention for Black women with obesity and a recent pregnancy complicated by gestational diabetes mellitus (GDM). The investigators will recruit women through Medicaid insurance plans (Priority Partners), clinical obstetric practice (Johns Hopkins Outpatient Center, Women's Health Center), perinatal community-based organizations (MOM Cares and Bloom Collective), and home-visiting locations (The Family Tree of Maryland)-all of which can verify clinical outcomes for participants.
At 37 weeks gestation, participants are contacted by the study team for consent, baseline data collection (baseline visit 1), and randomization 1:1 to receive the intervention vs. usual care (which begins in the first postpartum week). 3-7 days after randomization, the remainder of baseline visit information (baseline visit 2) is collected including information for the prepared MTF vendor (Moveable Feast Baltimore)
The intervention group will initially receive prepared MTF (low carbohydrate, and low-fat meals, which have been shown to improve glycemia in people with prediabetes) delivered by Moveable Feast (MFeast) (10 meals weekly; Tailored Medical Nutrition Therapy (MNT) delivered by dieticians from MFeast via monthly phone calls and focused on two high yield topics only: ↓sugar-sweetened beverages and ↑ fruit and vegetable consumption; Lactation nutritional snack bundles to boost milk supply + structural support for breastfeeding/ pumping via lactation consultants and pumping supply subsidization; culturally-adapted seasoning bundles; and dependent meal boxes for children in the household (i.e., will include 10 developmentally appropriate snack and small meal bundles, for up to 24 weeks. At postpartum week 8, participants will be offered a transition from prepared medically tailored meals to Instacart fresh food delivery (medically tailored via study team-crafted virtual grocery store) for 16 more weeks.
Those assigned to the "MFeast Usual Care" group will receive prepared MTF delivered by MFeast and as-needed MNT from 1 to 24 weeks postpartum.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Michelle S Ogunwole, MD PhD
- Telefonní číslo: 2143154936
- E-mail: sogunwo1@jhmi.edu
Studijní místa
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21205
- Nábor
- East Baltimore Medical Campus
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Age ≥18 years
- Self-identify as Black or African American
- Low-income (defined as eligible for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) benefits)
- Speak English as a primary language
- Identify as a primary meal planner/preparer
- Gestational diabetes
- Gestational age >37 weeks
- Have a BMI > 30 (calculated based on chart review of height and weight measurement)
- Willing to take part in the intervention and data collection procedures through online surveys
Exclusion Criteria:
- Mothers who have social support i.e. have family members preparing meals for the mother
- Mothers who are unlikely to be at the primary residence in the postpartum period
- Mothers with very specific dietary needs, i.e, food allergies, picky eaters, vegetarian / vegan
- Mothers whose birth outcome is a stillborn
- Mothers who have serious mental illness
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: MFeast ENHANCED
MFeast ENHANCED (a hybrid MTF intervention with a patient-activated transition from prepared meal to fresh food delivery, adaptations for postpartum people, structural and nutritional lactation support, cultural adaptations for engagement and adherence, and food provision for dependents) |
Intervention group will initially receive prepared MTF (low carbohydrate, low-fat meals, which have been shown to improve glycemia in people with prediabetes) delivered by MFeast (10 meals weekly); Tailored Medical Nutrition Therapy (MNT) delivered by dieticians from MFeast via monthly phone calls and focused on only: ↓sugar-sweetened beverages and ↑fruit and vegetable consumption; Lactation snack bundles to boost milk supply + structural support for breastfeeding/pumping via lactation consultants and pumping supply subsidization; culturally-adapted seasoning bundles; and dependent meal boxes for children in the household (i.e., will include 10 developmentally appropriate snack and small meal bundles, for up to 24 weeks. At postpartum week 8 participants will be offered a transition from prepared medically tailored meals to Instacart fresh food delivery (via study team-crafted virtual grocery store) for 16 more weeks. |
|
Aktivní komparátor: MFeast Usual Care
MFeast Usual Care (prepared medically tailored meals only). |
Those assigned to the "MFeast Usual Care" group will receive prepared MTF delivered by MFeast and as needed MNT from 1 to 24 weeks postpartum. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Participant Enrollment Rate
Časové okno: 6-8 months postpartum
|
Participant Enrollment Rate as assessed by the percentage of participants consented/enrolled compared to the total eligible participants |
6-8 months postpartum
|
|
Participant Retention
Časové okno: 6-8 months postpartum
|
Retention as assessed by the percentage of participants completing all study follow-up visits among all enrolled participants. |
6-8 months postpartum
|
|
Adherence as assessed by self-reported food consumption scores and photographs sent to the study team via secure messaging app
Časové okno: 6-8 months postpartum
|
Consumption scores range from 0%, 25%, 50%, 75%, or 100%, indicating the amount of food consumed the prior week (self and dependents scores reported). |
6-8 months postpartum
|
|
Satisfaction as assessed by focus groups and the 8 item Client Satisfaction Questionnaire- (CSQ-8)
Časové okno: 6-8 months postpartum
|
Participants rate satisfaction with the intervention's meal quality, delivery service, and likelihood of recommending the service to others at study completion, to assess the extent to which the intervention met their needs and preferences. Scores range from 8 to 32, with higher values indicating higher satisfaction. |
6-8 months postpartum
|
|
Participant Engagement assessed by frequency and quality of meal discussions
Časové okno: 1-6 months postpartum
|
Analyze the messaging app and Slack Channel to determine the frequency and quality of discussions about meals and recipes. |
1-6 months postpartum
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Dietary Quality as assessed by the Healthy Eating Index (HEI) 24-hour recall
Časové okno: Baseline, 3 and 6 months postpartum
|
The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines. |
Baseline, 3 and 6 months postpartum
|
|
Stress assessed by the 4-item Stress Scale.
Časové okno: Baseline, 3 and 6 months postpartum
|
The 4-item Stress Scale consists of 4 questions. The lowest total score is 0 and the highest total score on the scale is 16. Higher scores are correlated to more stress. |
Baseline, 3 and 6 months postpartum
|
|
Food Insecurity measured using a 6-item Food Insecurity scale.
Časové okno: Baseline, 3 and 6 months postpartum
|
The 6-item Food Insecurity scale uses a subset of the standard 18 item food security scale. The Scores on the scale range from 0-6 with 0-1 indicating high or marginal food security, 2-4 indicating low food security and 5-6 indicating very low food security |
Baseline, 3 and 6 months postpartum
|
|
Postpartum Weight Retention in pounds as assessed by the difference in self-reported pre-pregnancy weight and postpartum weights
Časové okno: Baseline, 3 and 6 months postpartum
|
Will be assessed by calculating the difference in self reported pre-pregnancy weight (with Electronic Health Record validation) and postpartum weights (study provided scales) |
Baseline, 3 and 6 months postpartum
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
2 hour plasma glucose levels assessed using Oral Glucose Tolerance Test (OGTT)
Časové okno: 4-12 weeks postpartum
|
Test will be done using 75 g oral glucose load with measurement of 2-hour plasma glucose levels. Obtained by electronic health records (EHR) or lab request. |
4-12 weeks postpartum
|
|
HbA1C
Časové okno: 3 and 6 months postpartum
|
HbA1C assessed by EHR or lab request |
3 and 6 months postpartum
|
|
Percent time spent in euglycemia as assessed by participant blinded Continuous Glucose Monitor (CGM) sensor
Časové okno: 3 and 6 months postpartum
|
Will be measured by % time in euglycemia (glucose 70-139) |
3 and 6 months postpartum
|
|
Percent time spent in hyperglycemia assessed by participant blinded CGM sensor
Časové okno: 3 and 6 months postpartum
|
Will be measured by % time with hyperglycemia (glucose >140) |
3 and 6 months postpartum
|
|
Postprandial glucose excursions assessed by participant blinded CGM sensor
Časové okno: 3 and 6 months postpartum
|
Postprandial glucose is calculated using the incremental area under the curve (AUCi) of blood glucose (mg/dL) over a period of time. The AUCi will be calculated for 1 hour (AUCi 0-60) after a meal. The participants will have the sensors on for 10 days, and will be asked to document their meals to correlate with calculated AUCi's. |
3 and 6 months postpartum
|
|
Mean daily glucose
Časové okno: 3 and 6 months postpartum
|
Mean daily glucose for 10 days in months 3 and 6 postpartum |
3 and 6 months postpartum
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Michelle S Ogunwole, MD, PhD, Johns Hopkins School of Medicine
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Urogenitální onemocnění
- Onemocnění endokrinního systému
- Poruchy výživy
- Ženské urogenitální onemocnění a těhotenské komplikace
- Metabolické choroby
- Nadměrná výživa
- Tělesná hmotnost
- Těhotenské komplikace
- Poruchy metabolismu glukózy
- Diabetes Mellitus
- Nadváha
- Obezita
- Patologické stavy, příznaky a symptomy
- Nutriční a metabolické nemoci
- Příznaky a symptomy
- Diabetes, gestační
- Těhotenství v obezitě
Další identifikační čísla studie
- IRB00350743
- U24DK132733 (Grant/smlouva NIH USA)
- K12AR084229 (Grant/smlouva NIH USA)
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .